Skip to main content
ConductScienceScienceDex

Raymond Felix Schinazi

NIH Rank #2405
Unclaimed recordClaim profile
  • R01 Holder
  • Early Career

Researcher identity and coverage

Current affiliation
Not verified in ScienceDex.NIH award organizations may differ from a researcher's employer.
NIH RePORTER identity
Profile ID 1884100Search this ID in NIH RePORTER
ScienceDex PI coverage
FY2024 through FY2026Career claims are limited to the years shown.

FY2026 award categories

  • Pediatrics

NIH Funding · FY2025

Linked Award Amount
$3.7M
Full award amounts, FY2025
Award Records
6
Records listing this PI
Award-Linked Rank
#2,405
By linked amount among FY2025 PIs
Earliest Year Loaded
2024
ScienceDex PI coverage

One scientist record

NIH portfolios and SHARE

This is the common ScienceDex page for Raymond Felix Schinazi. NIH portfolio memberships are contextual views of this scientist, while SHARE Score, S-Index, and S-Impact describe the researcher's global sharing track record.

Review metric definitions

FY2025 NIH portfolio memberships

No institute-level portfolio release is available for this scientist and fiscal year yet. Existing award history remains unchanged above.

Researcher-associated datasets

These datasets are linked to this researcher's ShareScore identity. This does not by itself prove that an NIH portfolio funded each dataset.

No compatible author-to-dataset release is published. Dataset records are unavailable, not zero.

Award-linked funding history

Linked NIH award amounts and rank by fiscal year.

FY2025 award records by amount

NIH award records listing Raymond Felix Schinazi as a PI. Multi-PI records show the full award amount for context.

  • 4R01AI173229-03R01
    Anti-norovirus protease inhibitors for immunocompromised patients
    Emory University
    $1.5M
    award amount
  • 5R01AI177696-02R01
    Discovery of Antivirals Targeting Mpox Virus
    Emory University
    $767.1K
    award amount
  • 5R01AI132833-08R01
    HBV Capsid Effectors
    Emory University
    $702.8K
    award amount
  • 5R01AI161570-05R01
    Broad-spectrum therapeutics against SARS-CoV-2 3CL protease
    Emory University
    $642.9K
    award amount
  • 1R13AI189261-01R13
    HIV-DART 2024
    Emory University
    $30K
    award amount
  • 1R13AI188976-01R13
    Respi-DART: Frontiers in drug development against respiratory viruses and emerging viruses
    Emory University
    $5K
    award amount

Award organization

Organizations that administered FY2025 awards listing Raymond Felix Schinazi as a PI.

FY2025 award administered by Emory University (GA).

Coverage and award-record milestones

Computed from the fiscal years currently available in ScienceDex.

  1. 2024
    First NIH Award
    Emory University
  2. 2024
    $500K Cumulative Funding
  3. 2024
    $1M Cumulative Funding
  4. 2024
    $2M Cumulative Funding
  5. 2024
    Entered Top 50% Nationally
    Ranked #2937
  6. 2024
    Entered Top 25% Nationally
    Ranked #2937
  7. 2025
    $5M Cumulative Funding
  8. 2025
    R01 Grant Holder

Shared-award investigators

Other investigators listed on at least one of the same NIH award records as Raymond Felix Schinazi.

Ladislau Christopher Kovari
Emory University
4
shared awards
Haian Fu
Emory University
3
shared awards
Stefan G Sarafianos
Emory University
3
shared awards
Elizabeth Ann Fitzpatrick
Emory University
2
shared awards
Asuncion Mejias
Emory University
1
shared award
David Bernard Smith
Emory University
1
shared award
Sijia Tao
Emory University
1
shared award

Explore further

Find collaborators for Raymond Felix Schinazi

Search NIH-funded principal investigators by topic, department, or activity.

Open Find Collaborators →

Benchmark grant budgets

Compare median NIH grant budgets across departments, mechanisms, and years.

Open Grant Budget Benchmark →